Proton beam therapy for the treatment of esophageal cancer

Steven H. Lin, Christopher Hallemeier, Michael Chuong

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Radiation therapy (RT) has become an important component in the curative management of esophageal cancer (EC) worldwide. Since most of the ECs seen in the Western hemisphere (i.e., Europe and the United States) are located in the mid- to distal-esophageal locations, heart and lungs invariably receive significant radiation doses. Much of the normal tissue exposure could be reduced with the utilization of advanced radiation technologies, notably intensity modulated radiation therapy (IMRT). Proton beam therapy (PBT) provides the ability to even further reduce normal tissue exposure because of its lack of exit dose, which is expected to provide clinically meaningful benefit for at least some EC patients. Herein, we provide an overview of the comparative effectiveness of proton versus photon therapy, summarize the published clinical experience, and describe the future outlook of PBT development in EC.

Original languageEnglish (US)
Article number53
JournalChinese Clinical Oncology
Volume5
Issue number4
DOIs
StatePublished - Jan 1 2016

Fingerprint

Proton Therapy
Esophageal Neoplasms
Radiotherapy
Radiation
Photons
Protons
Therapeutics
Technology
Lung

Keywords

  • Esophageal cancer (EC)
  • Intensity modulated radiation therapy (IMRT)
  • Proton therapy
  • Trimodality therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Proton beam therapy for the treatment of esophageal cancer. / Lin, Steven H.; Hallemeier, Christopher; Chuong, Michael.

In: Chinese Clinical Oncology, Vol. 5, No. 4, 53, 01.01.2016.

Research output: Contribution to journalReview article

@article{90129e637da0412a9ec0a750f2b06274,
title = "Proton beam therapy for the treatment of esophageal cancer",
abstract = "Radiation therapy (RT) has become an important component in the curative management of esophageal cancer (EC) worldwide. Since most of the ECs seen in the Western hemisphere (i.e., Europe and the United States) are located in the mid- to distal-esophageal locations, heart and lungs invariably receive significant radiation doses. Much of the normal tissue exposure could be reduced with the utilization of advanced radiation technologies, notably intensity modulated radiation therapy (IMRT). Proton beam therapy (PBT) provides the ability to even further reduce normal tissue exposure because of its lack of exit dose, which is expected to provide clinically meaningful benefit for at least some EC patients. Herein, we provide an overview of the comparative effectiveness of proton versus photon therapy, summarize the published clinical experience, and describe the future outlook of PBT development in EC.",
keywords = "Esophageal cancer (EC), Intensity modulated radiation therapy (IMRT), Proton therapy, Trimodality therapy",
author = "Lin, {Steven H.} and Christopher Hallemeier and Michael Chuong",
year = "2016",
month = "1",
day = "1",
doi = "10.21037/cco.2016.07.04",
language = "English (US)",
volume = "5",
journal = "Chinese Clinical Oncology",
issn = "2304-3865",
publisher = "Society for Translational Medicine (STM)",
number = "4",

}

TY - JOUR

T1 - Proton beam therapy for the treatment of esophageal cancer

AU - Lin, Steven H.

AU - Hallemeier, Christopher

AU - Chuong, Michael

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Radiation therapy (RT) has become an important component in the curative management of esophageal cancer (EC) worldwide. Since most of the ECs seen in the Western hemisphere (i.e., Europe and the United States) are located in the mid- to distal-esophageal locations, heart and lungs invariably receive significant radiation doses. Much of the normal tissue exposure could be reduced with the utilization of advanced radiation technologies, notably intensity modulated radiation therapy (IMRT). Proton beam therapy (PBT) provides the ability to even further reduce normal tissue exposure because of its lack of exit dose, which is expected to provide clinically meaningful benefit for at least some EC patients. Herein, we provide an overview of the comparative effectiveness of proton versus photon therapy, summarize the published clinical experience, and describe the future outlook of PBT development in EC.

AB - Radiation therapy (RT) has become an important component in the curative management of esophageal cancer (EC) worldwide. Since most of the ECs seen in the Western hemisphere (i.e., Europe and the United States) are located in the mid- to distal-esophageal locations, heart and lungs invariably receive significant radiation doses. Much of the normal tissue exposure could be reduced with the utilization of advanced radiation technologies, notably intensity modulated radiation therapy (IMRT). Proton beam therapy (PBT) provides the ability to even further reduce normal tissue exposure because of its lack of exit dose, which is expected to provide clinically meaningful benefit for at least some EC patients. Herein, we provide an overview of the comparative effectiveness of proton versus photon therapy, summarize the published clinical experience, and describe the future outlook of PBT development in EC.

KW - Esophageal cancer (EC)

KW - Intensity modulated radiation therapy (IMRT)

KW - Proton therapy

KW - Trimodality therapy

UR - http://www.scopus.com/inward/record.url?scp=84984861581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984861581&partnerID=8YFLogxK

U2 - 10.21037/cco.2016.07.04

DO - 10.21037/cco.2016.07.04

M3 - Review article

C2 - 27558254

AN - SCOPUS:84984861581

VL - 5

JO - Chinese Clinical Oncology

JF - Chinese Clinical Oncology

SN - 2304-3865

IS - 4

M1 - 53

ER -